Q5® Site-Directed Mutagenesis Kit

Site Directed Mutagenesis (SDM) Human - Point mutation A549 ABCA3

Experiment
Site Directed Mutagenesis (SDM) Human - Point mutation A549 ABCA3
Product
Q5® Site-Directed Mutagenesis Kit from New England BioLabs
Manufacturer
New England BioLabs

Protocol tips

Protocol tips
- Only use 1 μl of PCR product in the KLD reaction. Carrying too much PCR product forward can decrease transformation efficiency.

- Only use 5 μl of the KLD reaction in the transformation. If more KLD reaction is added, a buffer exchange step, such as PCR
purification, should be included prior to transformation.

Publication protocol

Plasmids
pT2/HB transposon vector was purchased from Addgene (plasmid #26557). First, the puromycin resistance gene with corresponding PGK promoter elements was amplified from pLKO.1puro vector (purchased from Addgene, plasmid #8453) and cloned into the pT2/HB vector using EcoRI and HindIII restriction sites, yielding pT2/HB-puro. Second, ABCA3 cDNA fused to a C-terminal HA-tag was amplified with corresponding cytomegalovirus (CMV) promoter elements from pcDNA4TO-ABCA3-HA vector and cloned into pT2/HB-puro using NheI and NotI restriction sites, yielding pT2/HB-puro-ABCA3-HA. The R288K point variant was introduced into pT2/HB-puro-ABCA3-HA using the Q5® site-directed mutagenesis kit with the following primers: R288K-for 5’-GAGAA GGAAA AGAGG CTGAA GGAGT AC-3’ and R288K-rev 5’-CTGCA CGACA GCACG GGC-3’. pCMV(CAT)T7-SB100 transposase was ordered from Addgene (plasmid #34879). All resulting vector constructs were verified using Sanger sequencing. Sequence analysis and alignment was done using Clone Manager Suite (Version 6.00).

Full paper   Login or join for free to view the full paper.

Reviews

Q5® Site-Directed Mutagenesis Kit from New England BioLabs has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Site Directed Mutagenesis (SDM) Human - Point mutation A549 ABCA3 using Q5® Site-Directed Mutagenesis Kit from New England BioLabs.

Paper title
Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from New England BioLabs for Q5® Site-Directed Mutagenesis Kit below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing Site Directed Mutagenesis (SDM) Human - Point mutation A549 ABCA3 using Q5® Site-Directed Mutagenesis Kit from New England BioLabs. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms